Lion's mane mushroom reduces depressive symptoms by stimulating NGF synthesis, supporting hippocampal neurogenesis, and modulating brain-derived neurotrophic factor (BDNF) levels — with clinical studies showing measurable mood improvement after 4 weeks of supplementation.
Lion's mane mushroom (Hericium erinaceus) is gaining recognition as a natural support for mental health, with research suggesting it may help address several neurochemical mechanisms involved in depression. Depression is a serious and common condition characterized by persistent low mood, loss of interest, feelings of hopelessness, and disrupted sleep, appetite, and cognition. It affects hundreds of millions of people globally and remains undertreated in many populations.
The Neuroscience Behind Depression
The development of depression involves multiple intersecting biological systems — not simply a «serotonin deficiency» as older models suggested. Current research identifies at least four overlapping mechanisms:
Neurotransmitter imbalances: Serotonin, norepinephrine, and dopamine regulate mood, motivation, sleep, and appetite. Disruption of these systems — through chronic stress, inflammation, or genetic vulnerability — is central to depressive symptoms. Most pharmaceutical antidepressants (SSRIs, SNRIs) work by modulating these pathways.
Reduced BDNF: Brain-derived neurotrophic factor (BDNF) is a protein that promotes neuron growth, survival, and synaptic plasticity. People with major depressive disorder consistently show lower BDNF levels, particularly in the hippocampus. Effective antidepressant treatments — including exercise, psychotherapy, and medication — all increase BDNF as part of their mechanism (Duman & Monteggia, 2006).
Neuroinflammation: Elevated pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) are found in a significant subset of depressed patients. These cytokines impair serotonin synthesis by upregulating the enzyme IDO, which diverts tryptophan away from serotonin production. Reducing neuroinflammation is increasingly recognized as a treatment target.
Impaired hippocampal neurogenesis: The hippocampus shrinks in chronic depression, and this structural change correlates with symptom severity. Restoring neurogenesis — new neuron growth in the hippocampus — is one mechanism through which exercise and antidepressants work. It's also one of lion's mane's most researched effects.
How Lion's Mane Addresses Depression's Mechanisms
Lion's mane works across several of the mechanisms described above — which is why researchers describe it as having a «multifaceted» antidepressant-like profile rather than a single-target action.
Monoamine restoration: Animal studies show that erinacin A (from lion's mane mycelium) restores serotonin, norepinephrine, and dopamine levels in the hippocampus of stressed mice. This effect is mediated partly through suppression of the inflammatory cascade that diverts tryptophan away from serotonin synthesis.
BDNF and neurogenesis activation: Erinacines activate the BDNF/TrkB/PI3K/Akt/GSK-3β signaling pathway — the same pathway targeted by antidepressant medications and exercise. This leads to increased BDNF expression, enhanced neuroplasticity, and stimulation of new neuron growth in the hippocampus. Lai et al. (2013, PMID 24266378) confirmed that hericenones and erinacines cross the blood-brain barrier and stimulate neurotrophin production in glial cells.
Anti-neuroinflammatory action: Lion's mane polysaccharides inhibit TNF-α, IL-6, and IL-1β production — reducing the neuroinflammatory burden that drives tryptophan depletion and synaptic dysfunction in inflammatory-subtype depression.
Human Clinical Evidence
Animal model findings are supported by at least two human trials directly relevant to mood.
Nagano et al. (2010, PMID 21107423) conducted a double-blind, placebo-controlled trial in 30 menopausal women over 4 weeks. The lion's mane group showed significantly lower scores on depression and anxiety measures compared to placebo. The researchers noted that reduced depression symptoms were accompanied by reduced irritability and improved concentration — suggesting effects across multiple mood-related domains, not just one.
Saitsu et al. (2019, PMID 31413233) found improvements in mood and anxiety in 31 adults over 12 weeks of lion's mane supplementation, alongside cognitive gains. While both trials are small, their double-blind design and statistical significance make them meaningful data points — not just anecdote.
The 16-week cognitive impairment trial (Mori et al., 2009, PMID 18844328) also reported reductions in depression and anxiety scores as secondary outcomes, reinforcing the mood-relevant effects across different populations.
Lion's Mane vs. Antidepressants: Key Differences
Lion's mane is not a pharmaceutical antidepressant. It doesn't inhibit serotonin reuptake, doesn't require a prescription, and doesn't carry the side-effect profile of SSRIs or SNRIs (sexual dysfunction, weight changes, discontinuation syndrome). For people with mild to moderate depressive symptoms — particularly those with an inflammatory or neuroplasticity component — it's a plausible adjunct or preventive support tool.
For moderate to severe depression, pharmaceutical treatment and psychotherapy remain the evidence-backed first line. Lion's mane should be viewed as a complementary option within a broader care plan, not a replacement for proven treatments. If you're already taking antidepressants, consult your prescriber before adding lion's mane, as the interaction profile has not been formally studied.
| Factor | Lion's Mane | SSRIs/SNRIs | |---|---|---| | Onset of effect | 4–8 weeks | 2–6 weeks | | Primary mechanism | NGF/BDNF, anti-inflammatory | Serotonin/norepinephrine reuptake inhibition | | Prescription required | No | Yes | | Side effects | Rare (mild GI, rare allergy) | Common (sexual dysfunction, GI, sleep changes) | | Discontinuation risk | None known | Withdrawal syndrome possible | | Evidence level | Small RCTs | Large Phase 3 trials |How to Incorporate Lion's Mane Into a Mental Health Routine
Lion's mane should not replace professional mental health support when that support is genuinely needed. If depression is significantly affecting daily functioning, clinical care comes first. For mild to moderate mood difficulties, or as a complement to an existing care plan, the approach is straightforward: take it consistently at the same time each day (typically morning), at 3 g/day of fruiting body powder or 500–1,000 mg of standardized extract, for at least 8–12 weeks.
Combining lion's mane with regular physical activity substantially improves the likelihood of noticing mood-related benefits — exercise independently supports neurogenesis and BDNF through mechanisms that overlap with the mushroom's. Adequate sleep, social connection, and stress management create the most supportive overall environment. Track your baseline mood weekly so that gradual improvements become visible rather than getting lost in day-to-day fluctuation.
You can find lion's mane products in our store:
1. Lion's mane fruits
2. Lion's mane capsules
3. Lion's mane extract
Frequently Asked Questions
Can lion's mane replace antidepressants for depression?
No — lion's mane is not a replacement for pharmaceutical antidepressants or psychotherapy in moderate to severe depression. It's a complementary support tool with plausible mechanisms and small clinical trials showing mood benefits. For mild depressive symptoms or as an adjunct to an existing treatment plan, it may be useful. Always consult your healthcare provider before changing or adding to an existing mental health regimen.
How long does lion's mane take to improve mood?
The Nagano et al. (2010) trial showed significant mood improvements after just 4 weeks of daily use in menopausal women. Other trials show cognitive and mood effects at 8–16 weeks. Individual response varies — some users report subtle mood lifting within 3–4 weeks, others need 8–12 weeks. Track weekly mood ratings from day one to detect gradual improvements that might otherwise go unnoticed.
What is the connection between lion's mane and BDNF?
BDNF (brain-derived neurotrophic factor) is a key protein for neuron survival, hippocampal neurogenesis, and synaptic plasticity. Low BDNF is a consistent finding in major depression. Lion's mane erinacines activate the BDNF/TrkB/PI3K/Akt signaling cascade — the same pathway stimulated by exercise and antidepressant medications — leading to increased BDNF expression and new neuron growth in the hippocampus.
Is lion's mane safe to take with antidepressants?
No serious drug interactions between lion's mane and antidepressants have been reported in the literature, and the mechanisms don't suggest obvious antagonism. However, the combination hasn't been formally studied in clinical trials. Because lion's mane may independently affect serotonin-related pathways and BDNF signaling, inform your prescriber before adding it to an existing medication regimen. This is especially important if you take MAOIs or are in a dose adjustment period.
Does lion's mane help with anxiety as well as depression?
Yes — both the Nagano 2010 trial and Saitsu 2019 trial showed improvements in anxiety scores alongside depression measures. The anti-neuroinflammatory and BDNF-activating mechanisms relevant to depression also apply to anxiety. Lion's mane's modulation of GABA-A receptor activity (reported in some preclinical studies) may additionally contribute to anxiolytic effects, though this pathway is less well-characterized in humans than the NGF/BDNF effects.
Related Articles
Sources
- Nagano M, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010. PMID 21107423
- Mori K, et al. Improving effects of the mushroom Yamabushitake on mild cognitive impairment. Phytother Res. 2009. PMID 18844328
- Saitsu Y, et al. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019. PMID 31413233
- Mori K, et al. Nerve growth factor-inducing activity of Hericium erinaceus. Biol Pharm Bull. 2008. PMID 18296328
- Lai PL, et al. Neurotrophic properties of the Lion's mane medicinal mushroom. Int J Med Mushrooms. 2013. PMID 24266378